Avalon AI uses Machine Learning to build tools for neuroradiologists that automatically measure and help visualize key brain features, enabling more accurate and faster diagnoses of brain diseases. They use the brain scans they collect to facilitate the recruitment of clinical trial patients and accelerate the development of a cure for neurodegenerative diseases like Alzheimer's.

Cymedix develops assays for the early detection of mitochondrial diseases such as Alzheimer's disease. Earlier detection enables earlier therapy, and development of personalized medicine solutions.

ADM Diagnostics, dba ADMdx, specializes in brain image analysis to enable diagnosis, prognosis, and drug effect detection for Alzheimer's disease and various other forms of dementia. The company provides pharmaceutical companies with powerful information to improve clinical trial success. ADMdx provides image data analysis and full CNS imaging study services with structural MRI, amyloid PET, tau PET, FDG PET, ASL, fMRI BOLD, and DTI. The company is developing diagnostic products to enable early, accurate disease detection supporting optimal patient care.

NeuroVision Imaging is developing retinal imaging technology for early detection and monitoring of Alzheimer's disease.

Neurotrack is a digital medicine solution for Alzheimer's disease, giving people direct access to the scientifically validated digital diagnostic and therapeutic to delay or prevent memory health conditions.

Darmiyan develops fully automated proprietary software that inputs human brain MRIs and produces maps that detect Alzheimer's disease up to fifteen years before symptoms. Its mission is to create a fast, non-invasive, inexpensive, precise, and globally accessible tool for brain health screening and monitoring. Darmiyan's technology provides a platform for presymptomatic diagnosis of neurodegenerative disorders, with precise quantification and localization of microscopic abnormality in the brain.